Eric Woolf
Eric Woolf has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
B.K Matuszewski
Department of Drug Metabolism, Merck Research Laboratories, West Point, PA 19486, USA
3 shared publicationsA Porras
Clinical Pharmacology Associates, Miami, Fla
1 shared publicationAbhishek Sharma
Advinus Therapeutics Ltd
1 shared publicationAmy Flynn
QPS LLC
1 shared publicationB Gertz
Clinical Pharmacology Associates, Miami, Fla
1 shared publicationB.K. Matuszewski
Department of Drug Metabolism, Merck Research Laboratories, West Point, PA 19486, USA
1 shared publication
Latest Publications
- Open Access
- 12 September 2024
- Published by Springer Nature in The AAPS Journal
- Vol. 26 (5) , 1-6
ICH M10 Bioanalytical Method Validation Guideline-1 year Later
The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) adopted Guideline M10 entitled "Bioanalytical Method Validation and Study Sample Analysis" in May 2022. In October 2023, approximately one year after the adoption of the ICH M10 guideline, a "Hot Topic" session was held during the AAPS PharmSci 360 meeting to discuss the implementation of the guideline. The session focused on items the bioanalytical community felt were challenging to implement or ambiguous within the guideline. These topics included cross-validation, parallelism, comparative bioavailability studies, combination drug stability, endogenous analyte bioanalysis, and dilution QCs. In addition, the regulatory perspective on the guideline was presented. This report provides a summary of the Hot Topic session. Graphical Abstract
- 12 September 2024
- Published by Springer Nature in The AAPS Journal
- Vol. 26 (5) , 1-6
Open AccessICH M10 Bioanalytical Method Validation Guideline-1 year Later
The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) adopted Guideline M10 entitled "Bioanalytical Method Validation and Study Sample Analysis" in May 2022. In October 2023, approximately one year after the adoption of the ICH M10 guideline, a "Hot Topic" session was held during the AAPS PharmSci 360 meeting to discuss the implementation of the guideline. The session focused on items the bioanalytical community felt were challenging to implement or ambiguous within the guideline. These topics included cross-validation, parallelism, comparative bioavailability studies, combination drug stability, endogenous analyte bioanalysis, and dilution QCs. In addition, the regulatory perspective on the guideline was presented. This report provides a summary of the Hot Topic session. Graphical Abstract
- 26 April 2017
- Published by Springer Nature
- p. 87-102
Regulated Bioanalysis—Historical Aspects and Key Concepts Related to Its Use
- 26 April 2017
- Published by Springer Nature
- p. 87-102
Regulated Bioanalysis—Historical Aspects and Key Concepts Related to Its Use
- 25 June 2014
- Published by Springer Nature in The AAPS Journal
- Vol. 16 (5) , 885-893
Small Molecule Specific Run Acceptance, Specific Assay Operation, and Chromatographic Run Quality Assessment: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Teams
Consensus practices and regulatory guidance for liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) assays of small molecules are more aligned globally than for any of the other...
- 25 June 2014
- Published by Springer Nature in The AAPS Journal
- Vol. 16 (5) , 885-893
Small Molecule Specific Run Acceptance, Specific Assay Operation, and Chromatographic Run Quality Assessment: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Teams
Consensus practices and regulatory guidance for liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) assays of small molecules are more aligned globally than for any of the other...
- 7 September 2001
- Published by Elsevier in Journal of Chromatography A
- Vol. 949 (1-2) , 83-89
Improved procedure for the the determination of rofecoxib in human plasma involving 96-well solid-phase extraction and fluorescence detection
- 7 September 2001
- Published by Elsevier in Journal of Chromatography A
- Vol. 949 (1-2) , 83-89
Improved procedure for the the determination of rofecoxib in human plasma involving 96-well solid-phase extraction and fluorescence detection
- 1 February 1999
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 65 (2) , 173
Influence of antacids on the bioavailability (F) of a specific cyclooxygenase (COX)-2 inhibitor, MK-0966 (M) in the elderly
- 1 February 1999
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 65 (2) , 173
Influence of antacids on the bioavailability (F) of a specific cyclooxygenase (COX)-2 inhibitor, MK-0966 (M) in the elderly
- 18 December 1998
- Published by Elsevier in Journal of Chromatography A
- Vol. 828 (1-2) , 229-238
Simultaneous determination of omeprazole and 5′-hydroxyomeprazole in human plasma by liquid chromatography–tandem mass spectrometry
- 18 December 1998
- Published by Elsevier in Journal of Chromatography A
- Vol. 828 (1-2) , 229-238
Simultaneous determination of omeprazole and 5′-hydroxyomeprazole in human plasma by liquid chromatography–tandem mass spectrometry
- 1 November 1998
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 18 (3) , 347-357
Effect of the sample matrix on the determination of indinavir in human urine by HPLC with turbo ion spray tandem mass spectrometric detection
- 1 November 1998
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 18 (3) , 347-357
Effect of the sample matrix on the determination of indinavir in human urine by HPLC with turbo ion spray tandem mass spectrometric detection